Interpretation of thrombosis indicators and prevention and treatment suggestions in the Guidelines for Quality Evaluation and Management of Intravenous Thromboembolism in Hospitals (2022 Edition)

DAI Rong-qin; LIU Yu-zhi; CHEN Yang; ZHANG Jin-biao; GUO Zhen-bin; LI Wei; GUO Dong-hui; GAO Feng; LU Yue

doi:10.16460/j.issn1008-9969.2024.13.035

PDF(842 KB)

Journal of Nursing ›› 2024, Vol. 31 ›› Issue (13) : 35-39. DOI: 10.16460/j.issn1008-9969.2024.13.035

Interpretation of thrombosis indicators and prevention and treatment suggestions in the Guidelines for Quality Evaluation and Management of Intravenous Thromboembolism in Hospitals (2022 Edition)

DAI Rong-qin¹, LIU Yu-zhi¹, CHEN Yang¹, ZHANG Jin-biao^2a, GUO Zhen-bin^2a, LI Wei^2b, GUO Dong-hui^2c, GAO Feng^2d, LU Yue^2e

Author information +

History +

Abstract

Objective To develop dialectical thinking in clinical staff to understand and apply hospital management and clinical diagnosis and treatment related guidelines with an evidence-based medicine concept. Methods We Interpreted "Guidelines for Quality Evaluation and Management of Intravenous Thromboembolism Prevention and Treatment in Hospitals (2022 Edition)", and propose prevention and treatment suggestions based on the indicator of thrombosis. Results This guideline proposed multiple objective quality management indicators for the prevention and treatment of venous thromboembolism (VTE), achieving qualitative and quantitative control of VTE, and had become an important basis and lever for clinical prevention and treatment of VTE. Thrombosis detection indicators can play a crucial role as objective basis in the prevention and treatment of VTE in clinical practice. Conclusion By adopting an evidence-based medicine approach and considering relevant testing indicators, the guideline has been interpreted. Through a comprehensive review of domestic and international literature, the thoughts and suggestions put forward in this study can serve as a valuable reference for future researchers in the field.

Key words

guideline interpretation / thrombosis indicator / thromboembolism / quality management

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

DAI Rong-qin, LIU Yu-zhi, CHEN Yang, ZHANG Jin-biao, GUO Zhen-bin, LI Wei, GUO Dong-hui, GAO Feng, LU Yue. Interpretation of thrombosis indicators and prevention and treatment suggestions in the Guidelines for Quality Evaluation and Management of Intravenous Thromboembolism in Hospitals (2022 Edition)[J]. Journal of Nursing. 2024, 31(13): 35-39 https://doi.org/10.16460/j.issn1008-9969.2024.13.035

References

[1] 全国肺栓塞和深静脉血栓形成防治能力建设项目专家委员会.医院内静脉血栓栓塞症防治质量评价与管理指南(2022版)[J].中华医学杂志,2022,102(42):3338-3348.DOI:10.3760/cma.j.cn112137-20220623-01373.
[2] 王振群,章文洁,吴俊.血栓分子标志物联合Caprini评分预测创伤性下肢骨折后深静脉血栓形成风险[J].中华检验医学杂志, 2021,44(12):1170-1175.DOI:10.3760/cma.j.cn114452-20210414-00237.
[3] 陶吟杰,施举红.不同生物标志物对评估肺血栓栓塞症危险分层的应用价值[J].中华结核和呼吸杂志, 2021,44(11):1009-1015.DOI:10.3760/cma.j.cn112147-20210820-00582.
[4] 曹盛吉,冯丹,吕明琪.恶性肿瘤患者血栓分子标志物变化及临床意义[J].中国老年学杂志,2020,40(4):756-759.DOI:10.3969/j.issn.1005-9202.2020.04.026.
[5] 郑洋洋,闫海润,李琪,等.恶性肿瘤患者血栓分子标志物的临床评价[J].中华检验医学杂志,2020,43(1):78-84.DOI:10.3760/cma.j.issn.1009-8158.2020.01.009.
[6] 中华医学会骨科学分会.中国骨科大手术静脉血栓栓塞症预防指南[J].中华骨科杂志,2016,36(2):65-71.DOI:10.3760/cma.j.issn.0253-2352.2016.02.001.
[7] 中华医学会骨科学分会创伤骨科学组.中国创伤骨科患者围手术期静脉血栓栓塞症预防指南[J].中华创伤骨科杂志,2021,23(3):185-192.DOI:10.3760/cma.j.cn115530-20201228-00795.
[8] 邱燕,田芹,马超.产前超声检查联合凝血标志物检测预测产后下肢深静脉血栓发生价值[J].中国计划生育学杂志,2023,31(1):144-147.DOI:10.3969/j.issn.1004-8189.2023.01.031.
[9] 王勇,鱼红进.凝血指标及血栓分子标志物水平对骨折患者术后深静脉血栓的预测价值[J].医学临床研究,2022,39(5):713-716.DOI:10.3969/j.issn.1671-7171.2022.05.020.
[10] 黄声淳,张劲丰,蔡惠兴,等.应用抗凝-纤溶标志物联合检测对髋关节置换术后静脉血栓进行诊断及疗效评估研究[J].标记免疫分析与临床,2019,26(2):294-298.DOI:10.11748/bjmy.issn.1006-1703.2019.02.028.
[11] 季洪良,闫本纯,郑洋洋,等.血栓分子标志物预测下肢骨折患者术后发生静脉血栓栓塞的价值[J].国际检验医学杂志,2020,41(20):2514-2517.DOI:10.3969/j.issn.1673-4130.2020.20.020.
[12] 张金彪,邢婉琳,曹蕾,等.血栓标志物对恶性肿瘤患者术后发生静脉血栓栓塞症的预测价值[J]. 肿瘤研究与临床,2022,34(2):106-110.DOI:10.3760/cma.j.cn115355-20210823-00367
[13] 褚玲玲,陈萍,冯丹,等. 肿瘤相关静脉血栓栓赛症防治指南的质量评价及内容分析[J].护理学报,2022,29(16):43-48.DOI:10.16460/j.issn1008-9969.2022.16.043
[14] Caprini JA.Risk assessment as a guide to thrombosis prophylaxis[J].Curr Opin Pulm Med,2010,16(5):448-452.DOI:10.1097/MCP.0b013e32833c3d3e.
[15] 王立群,段闪闪,廖灯彬,等.人工关节置换术后间歇充气压力泵使用时间对下肢深静脉血栓形成的影响[J].中国修复重建外科杂志,2020,34(5):585-590.DOI:10.7507/1002-1892.201907095.
[16] Zeng Y, Si H,Wu Y,et al.The incidence of symptomatic in-hospital VTEs in Asian patients undergoing joint arthroplasty was low:a prospective, multicenter, 17660-patient-enrolled cohort study[J].Knee Surg Sports Traumatol Arthrosc, 2019,27(4):1075-1082.DOI:org/10.1007/s00167-018-5253-3.
[17] 李汉平,麦金秀,黎雪梅,等.Caprini风险评估模型联合D-二聚体在子宫切除术围手术期静脉血栓栓塞性疾病中的诊断价值[J].中国医师进修杂志,2020,43(7):639-642.DOI:10.3760/cma.j.cn115455-20200115-00069.
[18] 王彦艳,王炎,刘延,等.Caprini血栓风险评估量表对外科手术患者静脉血栓栓塞症预测效果的Meta分析[J].中华现代护理杂志,2019,25(13):313-318.DOI:10.3760/cma.j.issn.1674-2907.2019.03.011.
[19] 张金彪,贾彩霞,卢越,等.结合《中国骨科大手术静脉血栓栓塞症预防指南(2016版)》谈血栓标志物的应用[J].护理研究, 2022, 36(13):2257-2262.DOI:10.12102/j.issn.1009-6493.2022.13.001
[20] 史冬立,李娜,张振美.深静脉血栓形成患者个案管理模式的建立与实践[J].护理学报,2020,27(15):17-20.DOI:10.16460/j.issn1008-9969.2020.15.017.
[21] 刘晶晶,陈丽萍,陈正香,等.创伤骨科血栓防控的多学科合作管理实践[J]. 2019,26(13):30-33.DOI:10.16460/j.issn1008-9969.2019.13.030.
[22] Michel E,Bertrand, Chair,Maarten L.Simoons,et al.Corrigendum to: 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)[J].European heart journal,2021,42(23):2298.DOI:10.1093/eurheartj/ehv320.
[23] 刘凤林,秦净.从指南到实践:解析《中国普通外科围手术期血栓预防与管理指南》[J].协和医学杂志,2018,9(2):144-149.DOI:10.3969/j.issn.1674-9081.2018.02.008.
[24] 中华医学会急诊医学分会心脑血管学组.中国急性血栓性疾病抗栓治疗共识[J]. 2019, 39(6):501-531.DOI:10.3969/j.issn.1002-1949.2019.06.001.
[25] 刘晓辉,宋景春,张进华,等.中国抗血栓药物相关出血诊疗规范专家共识[J].解放军医学杂志, 2022,47(12):1169-1179.DOI:10.11855/j.issn.0577-7402.2022.12.1169.
[26] 中国血栓性疾病防治指南专家委员会.中国血栓性疾病防治指南[J].2018,98(36):2861-2888.DOI:10.3760/cma.j.issn.0376-2491.2018.36.002.